StockData
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc. (APVO) shareholders

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.46−0.09 (-15.97%)

Close on Nov 17, 2026Market cap $830.71KP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
2.8%
0M of 2M shares
Institutional holders
9
1 new, 0 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Waqas Khatri
Joint filing with Ayrton Capital LLC (10.00%), Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (10.00%)
358,15010.00%13G (passive)Jun 30, 2025
Mark Angelo
Joint filing with YA II PN, Ltd. (9.99%), YA Global Investments II (U.S.), LP (9.99%) and 5 more
357,8429.99%13G (passive)Jun 16, 2025
Bigger Michael
Joint filing with Bigger Capital Fund L P (9.95%), Bigger Capital Fund GP, LLC (9.95%)
285,0009.95%13G (passive)Jun 18, 2025
Bigger Capital Fund L P
Joint filing with Bigger Capital Fund GP, LLC (6.20%), Bigger Michael (6.20%)
200,0006.20%13G (passive)Apr 3, 2025
Niowave, Inc.151,72312.20%13G (passive)May 25, 2026
Heights Capital Management, Inc.
Joint filing with CVI Investments, Inc. (6.30%)
83,8546.30%13G (passive) amendmentJun 30, 2026
CVI Investments, Inc.
Joint filing with Heights Capital Management, Inc. (8.20%)
83,8548.20%13G (passive) amendmentDec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of APVOValueChange% of portfolio
Gsa Capital Partners Llp21,5391.20%$96.00K+1,9010.01%
Vanguard Capital Management LLC12,7130.71%$56.45K–0.00%
Geode Capital Management, LLC10,8210.60%$48.04K−2,5160.00%
Vanguard Fiduciary Trust Co4,1420.23%$18.39K–0.00%
UBS Group AG7300.04%$3.24K−2,7150.00%
Osaic Holdings, Inc.3600.02%$1.60K–0.00%
SBI Securities Co., Ltd.1090.01%$484–0.00%
Barclays PLC310.00%$138New0.00%
Danske Bank A/S10.00%$4–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202690M2.8%1 / 12 / 00M0M
Q1 202690M3.0%4 / 21 / 50M0M
Q4 2025110M1.1%11 / 00 / 00M0M
Q1 201700M0.0%0 / 00 / 10M0M
Q4 201610M0.0%0 / 00 / 00M0M
Q3 201610M0.0%1 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

3 funds held APVO in Q2 2026, 55% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of APVOValue% of fundAs of
Vanguard Extended Market Index Fund12,7130.71%$56.45K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund8,9010.49%$43.70K0.00%May 31, 2026
Fidelity Series Total Market Index Fund1,5480.09%$7.60K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jeffrey G. LamothePresident and CEO, Director9610.05%Aug 10, 2026
Marvin L. WhiteExecutive Chair, Director1,6670.09%Aug 10, 2026
Daphne TaylorSVP, CFO6380.04%Aug 10, 2026
Dirk HuebnerSVP, CMO6380.04%Aug 10, 2026
SoYoung KwonSVP, GC, BD & Corp Affairs6380.04%Aug 10, 2026
Mary Jo JanatpourSVP, CSO0–May 28, 2026
Daniel Abdun-NabiDirector4000.02%Aug 10, 2026
Barbara Lopez KunzDirector4000.02%Aug 10, 2026
John NiederhuberDirector4000.02%Aug 10, 2026
Grady Grant IIIDirector1,1500.06%Aug 10, 2026
Zsolt HarsanyiDirector4000.02%Aug 10, 2026
Niowave, Inc.10% owner98,5225.47%Jun 22, 2026
Of America Na Bank10% owner––Oct 3, 2025
Bofa Securities, Inc.10% owner270.00%Oct 3, 2025
Of America Corp /De/ Bank10% owner––Oct 3, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Barbara Lopez Kunz
Director
Aug 6, 2026Option exercise+400––400
Zsolt Harsanyi
Director
Aug 6, 2026Option exercise+400––400
Daniel Abdun-Nabi
Director
Aug 6, 2026Option exercise+400––400
Dirk Huebner
SVP, CMO
Aug 6, 2026Option exercise+638––638
Dirk Huebner
SVP, CMO
Aug 6, 2026Tax withholding−156$4.07$635482
Jeffrey G. Lamothe
President and CEO, Director
Aug 6, 2026Option exercise+961––961
Grady Grant III
Director
Aug 6, 2026Option exercise+400––1,150
John Niederhuber
Director
Aug 6, 2026Option exercise+400––400
Marvin L. White
Executive Chair, Director
Aug 6, 2026Option exercise+1,666––1,667
Marvin L. White
Executive Chair, Director
Aug 6, 2026Tax withholding−406$4.07$1.65K1,261
SoYoung Kwon
SVP, GC, BD & Corp Affairs
Aug 6, 2026Option exercise+638––638
Daphne Taylor
SVP, CFO
Aug 6, 2026Option exercise+638––638
Marvin L. White
Executive Chair, Director
Jul 17, 2026Option exercise+1––1
Grady Grant III
Director
Nov 10, 2025Buy+13,513$1.49$20.13K13,514
SoYoung Kwon
SVP, GC, BD & Corp Affairs
Jul 17, 2025Option exercise+3––4
John Niederhuber
Director
Jul 17, 2025Option exercise+1––1
Daphne Taylor
SVP, CFO
Jul 17, 2025Option exercise+3––3
Grady Grant III
Director
Jul 17, 2025Option exercise+1––1
Marvin L. White
President and CEO, Director
Jul 17, 2025Option exercise+10––12
Zsolt Harsanyi
Director
Jul 17, 2025Option exercise+1––1
Barbara Lopez Kunz
Director
Jul 17, 2025Option exercise+1––1
Jeffrey G. Lamothe
EVP, COO
Jul 17, 2025Option exercise+5––6
Daniel Abdun-Nabi
Director
Jul 17, 2025Option exercise+1––1
Daphne Taylor
SVP, CFO
Mar 4, 2025Option exercise+1––18
Jeffrey G. Lamothe
EVP, COO
Mar 3, 2025Option exercise+2––36
SoYoung Kwon
SVP, GC, BD & Corp Affairs
Mar 3, 2025Option exercise+2––25
Marvin L. White
President and CEO, Director
Mar 3, 2025Option exercise+6––55
Daphne Taylor
SVP, CFO
Mar 2, 2025Option exercise+2––17
Jeffrey G. Lamothe
EVP, COO
Mar 2, 2025Option exercise+3––34
SoYoung Kwon
SVP, GC, BD & Corp Affairs
Mar 2, 2025Option exercise+2––23
Marvin L. White
President and CEO, Director
Mar 2, 2025Option exercise+8––49
SoYoung Kwon
SVP, GC, BD & Corp Affairs
Aug 8, 2024Option exercise+213––801
Jeffrey G. Lamothe
EVP, COO
Aug 8, 2024Option exercise+42––894
Jeffrey G. Lamothe
EVP, COO
Aug 8, 2024Option exercise+272––1,166
Daphne Taylor
SVP, CFO
Aug 8, 2024Option exercise+158––576
John Niederhuber
Director
Jun 2, 2024Option exercise+81––217
Zsolt Harsanyi
Director
Jun 2, 2024Option exercise+81––280
Grady Grant III
Director
Jun 2, 2024Option exercise+81––198
Daniel Abdun-Nabi
Director
Jun 2, 2024Option exercise+81––277
Barbara Lopez Kunz
Director
Jun 2, 2024Option exercise+81––198
John Niederhuber
Director
Jun 1, 2024Option exercise+7––136
Zsolt Harsanyi
Director
Jun 1, 2024Option exercise+7––199
Grady Grant III
Director
Jun 1, 2024Option exercise+7––117
Daniel Abdun-Nabi
Director
Jun 1, 2024Option exercise+7––196
Barbara Lopez Kunz
Director
Jun 1, 2024Option exercise+7––117
SoYoung Kwon
SVP, GC, BD & Corp Affairs
May 31, 2024Option exercise+42––588
Daphne Taylor
SVP, CFO
Mar 4, 2024Option exercise+1,584––18,411
SoYoung Kwon
SVP, GC, BD & Corp Affairs
Mar 3, 2024Option exercise+3,667––24,042
Jeffrey G. Lamothe
EVP, COO
Mar 3, 2024Option exercise+3,667––37,504
Marvin L. White
President and CEO, Director
Mar 3, 2024Option exercise+9,584––67,430
SoYoung Kwon
SVP, GC, BD & Corp Affairs
Mar 2, 2024Option exercise+3,667––20,375
Daphne Taylor
SVP, CFO
Mar 2, 2024Option exercise+3,667––16,827
Jeffrey G. Lamothe
EVP, COO
Mar 2, 2024Option exercise+5,500––33,837
Marvin L. White
President and CEO, Director
Mar 2, 2024Option exercise+12,917––57,846
Daphne Taylor
SVP, CFO
Jan 29, 2024Option exercise+792––13,160
Jeffrey G. Lamothe
EVP, COO
Jan 28, 2024Option exercise+1,833––28,337
Marvin L. White
President and CEO, Director
Jan 28, 2024Option exercise+4,792––44,929
Zsolt Harsanyi
Director
Aug 9, 2023Option exercise+3,571––8,475
Grady Grant III
Director
Aug 9, 2023Option exercise+3,571––4,880
Barbara Lopez Kunz
Director
Aug 9, 2023Option exercise+3,571––4,880

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
4.61%
0M shares short
Days to cover
1.9
At 0M shares a day
Change since last report
-26.2%
From 0M shares
Short volume, 20 days
42.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Aptevo Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 124,973 shares on Sep 4, 2026 over the last 90 days.

Congress trades

1 trade in Aptevo Therapeutics reported by 1 member of the House

MemberTypeTradedAmountFiled
Steve Cohen
TN09
SoldJun 24, 2019$470Jul 3, 2019

See a number that looks wrong?